Results 251 to 260 of about 1,243,460 (313)

Intrinsic Photoactive Star ZnPc–Poly(glutamate) Nanoplatforms for Multimodal Glioblastoma Therapy and Brain‐Targeted Delivery

Advanced Functional Materials, EarlyView.
An intrinsic photoactive star‐shaped zinc phtalocyanine‐poly(L‐glutamic acid) (ZnPc‐PGA) nanoplatform for multimodal glioblastoma (GBM) therapy and brain‐targeted elivery. A ZnPc‐PGA‐based multifunctional theranostic nanocarrier platform enables image‐guided, multimodal GBM therapy. ZnPc‐PGA nanocarriers support the integration of fluorescence imaging,
Amina Benaicha‐Fernández, Teodora Ranđelović, Ana Armiñán, Víctor Sebastián, Manuel Fuentes, Cristián Huck‐Iriart, Esther Masiá, Paula Carrascosa‐Marco, Pablo Juanes‐Velasco, Snežana Đorđević, Clara Bayona, Ignacio Ochoa, Maria Medel, Inmaculada Conejos‐Sánchez, María J. Vicent   +14 more
wiley   +1 more source

Small-molecule degron mimetics for targeted protein degradation. [PDF]

Essays Biochem
Liu X.
europepmc   +1 more source

Exploring an Alternative to mRNA Vaccine Cold Chain Storage: MRNA‐Lipid Nanoparticle Stability When Dried in a Polymer Matrix

Advanced Functional Materials, EarlyView.
The nanostructure, size, and function of mRNA‐loaded lipid nanoparticles are evaluated before drying, within polymer microneedles, and after rehydration. The results reveal the polymer and LNP loadings required to recover nanostructure and preserve the delivery performance in dry‐state formulations.
Brendan P. Dyett, Shahad K. Alsaiari, John L. Daristotle, Timothy A. Forster, Alicia Lau, Dhruv Varshney, Rania Afaneh, Andrew R. Hanna, Charles Sloane, David Mankus, Haitao Yu, Jiali Zhai, DongSoo Yun, Lisa H. Tostanoski, Abigail Lytton‐Jean, Dan H. Barouch, Charlotte E. Conn, Robert Langer, Ana Jaklenec, Calum J. Drummond   +19 more
wiley   +1 more source

Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation. [PDF]

Commun Chem
Furuhata T, Yoshida K, Fujita R, Miyamoto J, Moriyama C, Masuda-Ozawa T, Tsuchiya H, Saeki Y, Okamoto A.   +8 more
europepmc   +1 more source

Acyclic Glutarimide PROTAC Precursors Enable Controlled Protein Degradation and Expand Cereblon Ligand Space. [PDF]

ACS Med Chem Lett
Renner AC, Kargbo RB.
europepmc   +1 more source

The application of drug delivery systems based on targeted protein degradation chimeras in disease treatment strategies. [PDF]

J Nanobiotechnology
Lin W, Qiao E, Wang Z, Tang C, Li C, Lu J.   +5 more
europepmc   +1 more source

Structural plasticity of the membrane-bound protein degradation assembly supports bacterial adaptation to stress. [PDF]

Cell Rep
Iqbal N, Keller S, Ghanbarpour A.
europepmc   +1 more source

Cell type-specific spatiotemporal control of GFP-tagged protein degradation in mice. [PDF]

J Cell Biol
Prado-Mantilla A, Sheheen J, Underwood J, Lechler T.   +3 more
europepmc   +1 more source

Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradation

O’Connor S, Rutter ZJ, Cowan AD, Zeeb M, Binder F, Cao Y, Chakraborti S, Djukic S, Geist L, Hogg E, Kidd G, Krumb M, Langer S, Schmidt D, Martin L, McCrory EH, Padroni G, Puoti I, Simpson L, Sturbaut M, Crozier L, Vetma V, Zhang Q, McAulay K, Theis T, Ciulli A.   +25 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular Machines for Protein Degradation

ChemBioChem, 2005
AbstractOne of the most precisely regulated processes in living cells is intracellular protein degradation. The main component of the degradation machinery is the 20S proteasome present in both eukaryotes and prokaryotes. In addition, there exist other proteasome‐related protein‐degradation machineries, like HslVU in eubacteria.
Michael Groll, Matthias Bochtler, Hans Brandstetter   +2 more
exaly   +4 more sources